Here are the 10 biggest losers among healthcare stocks:
• Neurocrine Biosciences — down 8.9 percent
• Lannett Co — down 8.2 percent
• Horizon Pharma — down 6.9 percent
• Achillion Pharmaceuticals — down 6.5 percent
• Repligen — down 6.3 percent
• Acadia Pharmaceuticals — down 6 percent
• Arena Pharmaceuticals — down 6 percent
• Impax Laboratories — down 5.8 percent
• Incyte — down 5.6 percent
• Cardiovascular Systems — down 5.3 percent on three times the normal volume
More articles on ASC issues:
What is important for ASC leaders to know today? 3 key thoughts from Susan Kizirian
mHealth market to grow at CAGR of nearly 50% by 2020: 4 statistics on the market by service
3 ways to trim down ASC business office costs for more powerful revenue cycle management strategy
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
